The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recognized seven new fellows during a plenary session at the society’s 2025 annual meeting in New Orleans.
The SNMMI Fellowship, established in 2016, is based on distinguished volunteer service to the society, exceptional achievement in the field of nuclear medicine and molecular imaging, and excellence in at least one of three areas: scientific discovery and innovation, educational efforts, and clinical practice.
The new SNMMI Fellows are as follows:
- Jon A. Baldwin, DO, University of Alabama, Birmingham, AL. Baldwin currently serves on the SNMMI Board of Directors.
- Roy W. Brown, vice president of government affairs and strategic alliances at Curium Pharmaceuticals. Brown serves on the SNMMI Committee on Radiopharmaceuticals and is Curium’s representative to the SNMMI Value Initiative.
- Jan Grimm, MD, PhD, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York. Grimm is an associate editor for the Journal of Nuclear Medicine.
- Steven H. Liang, PhD, Emory University School of Medicine and the Emory Positron Emission Tomography Center, Atlanta. Liang is a past president of SNMMI’s Radiopharmaceutical Sciences Council.
- Osama R. Mawlawi, PhD, University of Texas MD Anderson Cancer Center, Houston. Mawlawi currently serves on SNMMI’s Ethics, Workforce Pipeline, Scientific Program, Awards, and CTN Research committees and on the Dosimetry Task Force.
- Jonathan McConathy, MD, PhD, University of Alabama, Birmingham, AL. McConathy currently serves on the Therapy Strategic Planning Task Force, the Theranostic Leadership & Operations Group, the Committee on Outreach, and the SNMMI Brain Imaging Outreach Group.
- Machaba Michael Sathekge, MD, PhD, University of Pretoria and Steve Biko Academic Hospital in Pretoria, South Africa. Sathekge also heads the South African Nuclear Medicine Research Infrastructure (NuMeRI) and is an international associate editor for the Journal of Nuclear Medicine.
